Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Embolization, Inc.

FDA 510(k) & PMA Approved Devices — 1 products

Total Devices1
Categories1
Latest FDA decision2025-05-15
TypeNumberDevice NameCodeDateActions
510(k) K250276 Nitinol Enhanced Device (NED)KRD2025-05-15 View

Related Clinical Trials

NCT01557036Aneurysm Study of Pipeline in an Observational RegistryTERMINATEDNCT02303925Feasibility of Superior Rectal Artery Embolization for the Treatment of Hemorrhoidal DiseaseCOMPLETEDNCT03457948Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver MetastasesCOMPLETEDNCT04057352Citadel Embolization Device StudyACTIVE_NOT_RECRUITINGNCT04289480Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial AneurysmsACTIVE_NOT_RECRUITINGNCT04410146The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)COMPLETEDNCT04456569Geniculate Artery Embolization for OsteoarthritisACTIVE_NOT_RECRUITINGNCT04523350Instylla HES Hypervascular Tumor Pivotal StudyCOMPLETEDNCT04682652Genicular Artery Embolization Vs Observation for Symptomatic Knee OsteoarthritisACTIVE_NOT_RECRUITINGNCT04816591Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCACOMPLETED
↑